IVEG members and other KOLS express their professional views on different aspects of retinal pathologies and intravitreal injection therapy. Including highlights from major ophthalmology meetings.

Rufino Silva, MD, PhD, speaks about the ATLANTIC study, investigating the efficacy and safety of afl

LEARN MORE

What makes aflibercept the agent of choice for diabetic eye disease?LEARN MORE

What are the benefits of using aflibercept with a proactive T&E approach in patients with PCV?

LEARN MORE

What are the benefits of treating AMD patients with aflibercept at regular intervals? Two experts di

LEARN MORE
Older »

There are no more Expert Perspective content.

Error